amifostine anhydrous has been researched along with Atrophy in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macková, NO | 1 |
| Fedorocko, P | 1 |
1 other study available for amifostine anhydrous and Atrophy
| Article | Year |
|---|---|
Effects of immunomodulators on postirradiation recovery in the thymus.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Amifostine; Animals; Atrophy; Bacteria; C | 1997 |